Cargando…

Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis

N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with multiple symptoms including memory loss, seizure, psychosis, aphasia, altered mentality, dyskinesia, autonomic dysfunction, and central hypoventilation. While immunotherapy protocols are improving, morbidity and mortality in the diseas...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Soon-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Encephalitis and Neuroinflammation Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295877/
https://www.ncbi.nlm.nih.gov/pubmed/37492492
http://dx.doi.org/10.47936/encephalitis.2020.00045
_version_ 1785063525268324352
author Lee, Soon-Tae
author_facet Lee, Soon-Tae
author_sort Lee, Soon-Tae
collection PubMed
description N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with multiple symptoms including memory loss, seizure, psychosis, aphasia, altered mentality, dyskinesia, autonomic dysfunction, and central hypoventilation. While immunotherapy protocols are improving, morbidity and mortality in the disease largely depend on supportive care to control intractable symptoms. However, no prospective or controlled trials have been conducted on immunotherapy or supportive care principles in the disease. Thus, this study discusses and shares experience and ideas for symptomatic care of NMDAR encephalitis.
format Online
Article
Text
id pubmed-10295877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Encephalitis and Neuroinflammation Society
record_format MEDLINE/PubMed
spelling pubmed-102958772023-07-25 Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis Lee, Soon-Tae Encephalitis Review Article N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with multiple symptoms including memory loss, seizure, psychosis, aphasia, altered mentality, dyskinesia, autonomic dysfunction, and central hypoventilation. While immunotherapy protocols are improving, morbidity and mortality in the disease largely depend on supportive care to control intractable symptoms. However, no prospective or controlled trials have been conducted on immunotherapy or supportive care principles in the disease. Thus, this study discusses and shares experience and ideas for symptomatic care of NMDAR encephalitis. Korean Encephalitis and Neuroinflammation Society 2021-01 2020-12-21 /pmc/articles/PMC10295877/ /pubmed/37492492 http://dx.doi.org/10.47936/encephalitis.2020.00045 Text en Copyright © 2021 Korean Encephalitis and Neuroinflammation Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Lee, Soon-Tae
Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
title Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
title_full Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
title_fullStr Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
title_full_unstemmed Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
title_short Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
title_sort symptomatic treatments of n-methyl-d-aspartate receptor encephalitis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295877/
https://www.ncbi.nlm.nih.gov/pubmed/37492492
http://dx.doi.org/10.47936/encephalitis.2020.00045
work_keys_str_mv AT leesoontae symptomatictreatmentsofnmethyldaspartatereceptorencephalitis